Datamonitor reports and MedTRACK database special offer to the BiotechEast community

As part of BiotechEast's program of providing quality and timely information resources that deliver real benefits to your business, we have negotiated an exclusive industry partnership with Datamonitor, to provide significant discounts on reports and databases.

As part of the offer, the BiotechEast subscriber and reader community will be able to purchase reports at a 65% discount on their standard price. Therefore reports with a list price of US$3,400 will now be available for US$1,190.

Please note that this offer applies only to Taiwan-based companies, institutes or individuals.

Datamonitor reports which are available as part of this deal can be located at the following links:

• Arthritis
• Cardiovascular
• Gastroenterology
• Immunology
• Infectious Disease
• Metabolic Disorders
• Neurology
• Oncology
• Pain
• Psychiatry
• Respiratory
• Women's Health and Urology
• 21st Century Insights

MedTRACK is a fully integrated research and information resource that can track the product pipeline progression of more than 10,500 biomedical companies by therapeutic indication, product and trial details, and financial information.

The database is designed to enable industry professionals to look at public and private companies that are working in a particular therapeutic area and quickly determine where they rank clinically as well as financially.

As part of the offer, the BiotechEast reader community will be able to purchase a 12 month subscription to the MedTRACK database for a significantly discounted fee.

To confirm an order at the discounted rates, please send an email to khicks@datamonitor.com stating that you are a BiotechEast subscriber or reader and are based in Taiwan, and the title of the reports/ databases you would like to order at the special rate. Alternatively you can call Datamonitor at +61 2 8705 6922 (Karl Hicks), or contact BiotechEast at +886 2 2702 8100 (David Silver).

In order to take advantage of this offer, participants must be current readers or subscribers to BiotechEast. The offer applies only to Taiwan-based companies, institutes or individuals. Its main focus is to provide small to medium sized organisations with affordable access to Datamonitor reports and databases.

Datamonitor reserves the right to review eligibility of all participants.

About Datamonitor

Drawing on over 15 years of market-leading analysis, we offer actionable, strategic advice on market potential, portfolio management, and product marketing-related issues along the entire lifecycle of a drug. We aspire to be a first-stop shop in pharmaceutical and healthcare research, analysis, and problem-solving, for commercial, R&D, and business development issues, based on industry-recognized knowledge and analytical expertise.

Our team consists of more than 60 experienced analysts and consultants who continuously track and analyze the healthcare market.

Our flagship product is the new Pharmaceuticals and Healthcare Knowledge Center - a first-stop research tool that offers an entirely new concept in business information provision that's set to revolutionize the way you find and use information in your day-to-day work.

About MedTRACK

NEW!!! Special offer for BiotechEast subscribers

As part of the offer, the BiotechEast reader community will be able to purchase a 12 month subscription to the MedTRACK database for a significantly discounted fee.

MedTRACK is a fully integrated research and information resource that can track the product pipeline progression of more than 10,500 biomedical companies by therapeutic indication, product and trial details, and financial information.

The database is designed to enable industry professionals to look at public and private companies that are working in a particular therapeutic area and quickly determine where they rank clinically as well as financially.

In addition, MedTRACK provides extensive research tools that allow you to customize your enquiries; select individualized search criteria, merge information on the financial statements and pipelines of two or more companies, and conduct searches of companies and their respective products by geography, mechanism of action, or by patent expiration.

The main MedTRACK database product incorporates many features and resources.

The Disease Hub organizes company information according to area of research and product development. Choose from 17 specific disease categories and more than 800 subcategories, including cancer, cardiovascular and circulatory system, genetic diseases and dysmorphic syndromes, and respiratory and pulmonary system, and view pipeline and financial data, stock quotes, a business description, product summaries and details, corporate trademarks, corporate partners and officers, and more.

The Industry Hub organizes data into 38 industry categories (biotechnology/ biopharmaceutical, gene/cell therapy, pharmaceuticals, etc), further divided into more than 1000 subcategories, and displays current and important information for each company listed, including key financial data, and valuation and growth ratios.

The Company Explorer section that lets you track firms based on 18 different parameters, and a Drug Patent Expiry database searchable by patent and market exclusivity expiration dates, active ingredient, product name, and company name.

The Geographical Search tool to explore and investigates companies based on their geographical location.

The Merger Tool allows the user to combine and compare the pipeline and financial information of public and private companies.

Drug Classification: MedTRACK has implemented the EphMRA Drug Classification system, which provides a global standard for classifying medical substances. It is a useful tool for locating and comparing companies working within a specific drug class.

Extended Product Profiles: The database includes highly detailed Extended Product Profiles for many Phase II and Phase III products. These extended descriptions include pharmacology, clinical trial history, and regulatory information.

Milestone Calendar: The milestone calendar provides important upcoming events such as PDUFA dates that could impact a company's status, affect the competition, or move a company's stock.

Product Sales: Historical data for selective US and international sales is provided in tabular and interactive graphical format.

MOA: The database allows users to search for products based on their mechanism of action or determine how novel an approach or product may be.

Pipeline Profiling: This tool allows users to identify companies with comparable valuations based upon pipeline, or to determine relative private company valuations by identifying public companies with comparable pipelines.

Screener: Finds all companies that match chosen criteria such as therapeutic area, stage of development, geographical area, and financial variables (for US public companies).

Deals and alliances database
The MedTRACK database now includes the deals and alliances database, which provides comprehensive coverage of licensing agreements and other deals by more than 10,500 biomedical companies covered in MedTRACK. Historically it has deals broken down by type – development, license, collaboration, research, distribution, marketing, supply etc. Deals are also broken down by 20 different therapeutic categories. These are then broken down by the stage of development – On the market, clinical phase (I, II, III), pending approval etc. Information is also provided by the financial terms, e.g. royalty, milestone, funding, upfront cash, payments, licensing fees, equity, profit sharing, and development fees. The database has a daily newsfeed which provides updates on deals and alliances, as well as mergers and acquisitions as they occur. Both MedTRACK and the Deals and Alliances database are provided through the same front end, and so will only require the single login.

MedTRACK Analytics
MedTRACK Analytics defines a set of metrics that evaluates a company compared to its competitors as well as a broader industry index. Subscribers can access a unique ranking system that combines 35 analytical measurements into six metric classes, including Pipeline Metrics, which represents an evaluation and comparison of a company’s pipeline to a representative group of competitors and a related index.

The final scores for each metric are weighted and combined into a global LSA Index that reflects the overall assessment of the company. Select from data into an Industry Index (Amex Pharma, Emerging Biotech Index, etc), competitive analysis of specific companies, and pre-prepared company reports.